BioSpace Collaborative

Academic/Biomedical Research
News & Jobs
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  C2C Services & Suppliers™
Europe
Asia

DIVERSITY

PROFILES
Company Profiles

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Research Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search
 Company Profile

 

Suven Life Sciences Ltd 

Serene Chambers
Road No. 5, Avenue - 7, Banjara Hills
Hyderabad    500 034  India
Phone: 91-40-2354-1142 Fax: 91-40-2354-1152


SEARCH JOBS




Industry
Biotechnology

Segment
Life Sciences





 Company News
Suven Life Sciences Ltd Secures Five (5) Product Patents For Their Nces In Australia, Europe, Hong Kong, Israel And Norway 4/24/2015 8:37:36 AM
Suven Life Sciences Ltd Initiated Multiple Ascending Dose (MAD) Studies In Phase 1 Clinical Trial For Their Investigational Compound SUVN-G3031 4/13/2015 9:10:43 AM
Suven Life Sciences Ltd Secures Three (3) Product Patents For Their NCEs In Canada, Japan And Korea 3/24/2015 9:10:39 AM
Suven Life Sciences Ltd Secures 2 (Two) Product Patents For Their NCE’s Through New Mechanism Of Action - H3 Inverse Agonist In USA & New Zealand 3/16/2015 10:26:48 AM
Suven Life Sciences Ltd Secures One (1) Product Patent Each In Eurasia And Israel 3/9/2015 8:56:04 AM
Suven Life Sciences Ltd Secures 4 (Four) Product Patents For Their NCE’s Through New Mechanism Of Action – H3 Inverse Agonist In Australia, Canada, Japan And New Zealand 2/16/2015 10:51:20 AM
Suven Life Sciences Ltd Revenue Growth At 9% While PAT Is Down By 11.55% For The 3rd Quarter Ended Dec 2014 2/10/2015 8:50:37 AM
Suven Life Sciences Ltd Secures One (1) Product Patent Each In Australia & Hong Kong, Two (2) Product Patents From Japan 1/20/2015 1:06:03 PM
Suven Life Sciences Ltd Secures Three (3) Product Patents In Eurasia, Japan, And Mexico 12/30/2014 2:03:52 PM
Suven Life Sciences Ltd Secures (5) Product Patents For Their Nces In Israel, Japan, China And New Zealand 12/12/2014 9:16:26 AM
12345678910